Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Osimertinib improves progression-free survival in NSCLC.

× No keyword cloud information.

6 in total

1. Caspase-8 knockdown suppresses apoptosis, while induces autophagy and chemo-sensitivity in non-small cell lung cancer cells.

Authors: Hui Zuo; Cheng Chen; Ling Ma; Qiu-Xia Min; Yue-Hai Shen
Journal: Am J Transl Res Date: 2020-10-15 Impact factor: 4.060

2. YL143, a novel mutant selective irreversible EGFR inhibitor, overcomes EGFR^{L858R, T790M} -mutant resistance in vitro and in vivo.

Authors: Zhang Zhang; Jian Zou; Lei Yu; Jinfeng Luo; Yan Li; Zhengchao Tu; Xiaomei Ren; Hongcheng Wei; Liyan Song; Xiaoyun Lu; Ke Ding
Journal: Cancer Med Date: 2018-03-13 Impact factor: 4.452

3. Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI.

Authors: John Wen-Cheng Chang; Chen-Yang Huang; Yueh-Fu Fang; Ching-Fu Chang; Cheng-Ta Yang; Chih-Hsi Scott Kuo; Ping-Chih Hsu; Chiao-En Wu
Journal: Cancers (Basel) Date: 2022-02-15 Impact factor: 6.639

Review 4. Current treatments for non-small cell lung cancer.

Authors: Qianqian Guo; Liwei Liu; Zelong Chen; Yannan Fan; Yang Zhou; Ziqiao Yuan; Wenzhou Zhang
Journal: Front Oncol Date: 2022-08-11 Impact factor: 5.738

5. Development and validation of a survival model for lung adenocarcinoma based on autophagy-associated genes.

Authors: Xiaofei Wang; Shuang Yao; Zengtuan Xiao; Jialin Gong; Zuo Liu; Baoai Han; Zhenfa Zhang
Journal: J Transl Med Date: 2020-04-01 Impact factor: 5.531

6. A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer.

Authors: Wanjun Yu; Fei Ye; Xiao Yuan; Yali Ma; Chaoming Mao; Xiaoqin Li; Jian Li; Chunhua Dai; Fenhong Qian; Junrong Li; Xiujuan Fan; Yuepeng Zhou; Deqiang Wang; Zhenhong Guo; Huazhang An; Minghui Zhang; Deyu Chen; Sheng Xia
Journal: BMC Cancer Date: 2021-07-31 Impact factor: 4.430